Chardan Capital analyst Keay Nakae downgrades Exicure (NASDAQ:XCUR) from Buy to Neutral and lowers the price target from $2.25 to $0.4.Chardan Capital analyst Keay Nakae downgrades Exicure (NASDAQ:XCUR) from Buy to Neutral and lowers the price target from $2.25 to $0.4.